Letter to the Editor
CytoSorb therapy for infective endocarditis: Expectations and a question of patient phenotype?
Terapia CytoSorb en endocarditis infecciosa: ¿expectativas y una cuestión de fenotipo de pacientes?
Nandor Marczina,b, Shahzad Rajac, Daniel Wendtd,e,
, Harriet Adamsone, Victoria Rizzof
Autor para correspondencia
a Department of Anaesthesia and Critical Care, Harefield Hospital, London, United Kingdom
b Faculty of Medicine, Department of Surgery & Cancer, Imperial College, London, United Kingdom
c Department of Cardiac Surgery, Harefield Hospital, London, United Kingdom
d Faculty of Medicine, University Hospital Essen, Essen, Germany
e CytoSorbents Berlin GmbH, Berlin, Germany
f Cardiothoracic Surgery, St. Thomas Hospital, Guy's and St Thomas’ NHS Foundation Trust, London, United Kingdom
Leído
724
Vecesse ha leído el artículo
223
Total PDF
501
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 17 | 7 | 24 |
| 2025 11 | 100 | 66 | 166 |
| 2025 10 | 38 | 17 | 55 |
| 2025 9 | 44 | 26 | 70 |
| 2025 8 | 49 | 28 | 77 |
| 2025 7 | 54 | 23 | 77 |
| 2025 6 | 47 | 13 | 60 |
| 2025 5 | 37 | 5 | 42 |
| 2025 4 | 23 | 5 | 28 |
| 2025 3 | 29 | 9 | 38 |
| 2025 2 | 19 | 7 | 26 |
| 2025 1 | 17 | 1 | 18 |
| 2024 12 | 27 | 16 | 43 |
Mostrar todo
